Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Horowitz

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Annals of Internal Medicine|December 31, 1997
Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysisS J Lee, K M Kuntz, M M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow TransplantationC S Chen, K Seidel, J O Armitage, et al.
Blood|November 24, 2001
The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phaseS J Lee, J P Klein, C Anasetti, et al.
The New England Journal of Medicine|March 27, 1997
Solid cancers after bone marrow transplantationR E Curtis, P A Rowlings, H J Deeg, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
Leukemia Research|August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remissionR P Gale, R E Park, R W Dubois, et al.
Leukemia Research|October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remissionR P Gale, R E Park, R W Dubois, et al.
Bone Marrow Transplantation|May 21, 2008
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric populationJ E Levine, A J Barrett, M-J Zhang, et al.
Leukemia Research|September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phaseR P Gale, R E Park, R W Dubois, et al.
Bone Marrow Transplantation|August 16, 2016
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysisP V O'Donnell, M Eapen, M M Horowitz, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Annals of Internal Medicine|December 31, 1997
Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysisS J Lee, K M Kuntz, M M Horowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow TransplantationC S Chen, K Seidel, J O Armitage, et al.
Blood|November 24, 2001
The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phaseS J Lee, J P Klein, C Anasetti, et al.
The New England Journal of Medicine|March 27, 1997
Solid cancers after bone marrow transplantationR E Curtis, P A Rowlings, H J Deeg, et al.
Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.
Leukemia Research|August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remissionR P Gale, R E Park, R W Dubois, et al.
Leukemia Research|October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remissionR P Gale, R E Park, R W Dubois, et al.
Bone Marrow Transplantation|May 21, 2008
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric populationJ E Levine, A J Barrett, M-J Zhang, et al.
Leukemia Research|September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phaseR P Gale, R E Park, R W Dubois, et al.
Bone Marrow Transplantation|August 16, 2016
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysisP V O'Donnell, M Eapen, M M Horowitz, et al.
Pageof 15